Published in Pharma Investments, Ventures and Law Weekly, February 12th, 2006
Sepracor's purchase was made at a price of approximately $12.29 per share, which represented a 25% premium to the 30-day trailing average closing price as of the 1-year anniversary of the collaboration, and resulted in the issuance of 813,393 shares of Acadia common stock.
"We are excited with the progress of our collaboration with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.